HealthLynked Corp.
HLYK
$0.04
-$0.0004-0.99%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -57.55% | -53.28% | -42.69% | -33.58% | -3.23% |
| Total Other Revenue | 74.19% | -57.29% | -53.37% | -57.02% | 1,450.00% |
| Total Revenue | -55.71% | -53.33% | -42.79% | -33.78% | -1.94% |
| Cost of Revenue | -40.80% | -42.30% | -38.36% | -39.02% | -9.42% |
| Gross Profit | -79.07% | -66.69% | -48.58% | -19.16% | 12.65% |
| SG&A Expenses | -17.70% | 3.33% | -9.45% | 2.18% | -29.45% |
| Depreciation & Amortization | -5.38% | -3.40% | -1.82% | -57.38% | -58.28% |
| Other Operating Expenses | -33.94% | -39.77% | -22.69% | -39.38% | -23.90% |
| Total Operating Expenses | -29.67% | -25.06% | -22.39% | -27.29% | -23.99% |
| Operating Income | -10.45% | -35.26% | -11.49% | 20.79% | 43.54% |
| Income Before Tax | -1,122.49% | -55.75% | -17.82% | 68.47% | 89.49% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1,122.49% | -55.75% | -17.82% | 68.47% | 89.49% |
| Earnings from Discontinued Operations | -- | -- | -- | 100.00% | 94.53% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1,028.13% | -53.50% | -195.58% | 69.92% | 90.20% |
| EBIT | -10.45% | -35.26% | -11.49% | 20.79% | 43.54% |
| EBITDA | -11.17% | -36.93% | -11.99% | -29.21% | 44.42% |
| EPS Basic | -900.00% | -41.03% | -187.50% | 72.09% | 90.91% |
| Normalized Basic EPS | -20.83% | -43.48% | -7.41% | 19.44% | 44.19% |
| EPS Diluted | -1,328.57% | -156.41% | -187.50% | 72.09% | 93.64% |
| Normalized Diluted EPS | -20.83% | -43.48% | -7.41% | 19.44% | 44.19% |
| Average Basic Shares Outstanding | 6.19% | 8.46% | 9.08% | 6.05% | 9.11% |
| Average Diluted Shares Outstanding | 6.19% | 8.46% | 9.08% | 6.05% | 9.11% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
